UC-II Collagen for Joint Comfort
Small trials report better symptom relief than glucosamine plus chondroitin, but sponsorship is a concern.
Overview
Verdict
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- 40 mg/day of UC-II undenatured type II collagen, taken at bedtime on an empty stomach
- Expected timeframe
- 3-6 months
Protocol
- form
- Undenatured (native) type II collagen from chicken sternal cartilage; this is not the same as hydrolysed collagen peptides, which are used at 10 g/day for different reasons
- duration
- 90-180 days; trials generally showed separation from placebo by 90 days
- co factor
- Take on an empty stomach, at least 30 minutes before or 2 hours after food, since digestion may denature the collagen and defeat the mechanism. Evidence is mixed. Randomised trials at 40 mg/day report reduced WOMAC pain and stiffness in knee osteoarthritis, with Lugo and colleagues finding UC-II superior to both placebo and to glucosamine plus chondroitin over 180 days, and a further trial showing benefit in healthy subjects with exercise-induced joint discomfort. The limitation is that nearly all trials come from or are funded by the ingredient manufacturer, with few independent replications and modest sample sizes.
- titration
- None - 40 mg/day is the fixed dose used across trials, and the oral tolerance mechanism does not favour higher doses
- starting dose
- 40 mg/day of UC-II, taken at bedtime on an empty stomach
Evidence
What the studies say
Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial
Crowley DC, Lau FC, Sharma P
UC-II reduced WOMAC, VAS and Lequesne scores more than glucosamine plus chondroitin
Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study
Lugo JP, Saiyed ZM, Lane NE
Undenatured type II collagen significantly improved total WOMAC score and knee function versus placebo
Effect of collagen supplementation on osteoarthritis symptoms: a meta-analysis of randomized placebo-controlled trials
García-Coronado JM, Martínez-Olvera L, Elizondo-Omaña RE +4 more
Collagen supplementation improved osteoarthritis symptom scores across pooled randomized trials
Undenatured type II collagen (UC-II) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers
Lugo JP, Saiyed ZM, Lau FC
UC-II extended time to onset of exercise-induced knee joint pain and improved knee extension
Safety
Caveats
The evidence base is almost entirely manufacturer-funded, which is a genuine limitation for interpreting effect sizes, though the trials themselves are randomised and placebo-controlled. Exercise therapy and weight loss remain the best-evidenced interventions for knee osteoarthritis, outperforming any supplement and most drugs, and topical NSAIDs are effective with low systemic risk. Safety of UC-II: well tolerated at 40 mg/day, with occasional mild gastrointestinal upset; no upper limit is established, but there is no reason to exceed the studied dose. It is derived from chicken sternal cartilage, so it is unsuitable for vegetarians and vegans and must be avoided by anyone with chicken or egg protein allergy. The mechanism involves immune modulation through oral tolerance, so caution is sensible in autoimmune conditions and with immunosuppressants. Safety in pregnancy and breastfeeding is not established. Do not take it with food or with hot drinks. Joint pain with heat, redness, fever, rapid swelling, or symmetrical small-joint involvement with prolonged morning stiffness needs medical assessment rather than a supplement.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.